Johnson & Johnson (BIT:1JNJ)
Italy flag Italy · Delayed Price · Currency is EUR
205.50
-0.10 (-0.05%)
Last updated: Mar 6, 2026, 1:55 PM CET

Johnson & Johnson Company Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand.

The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson
Country United States
Founded 1886
Industry Pharmaceutical Preparations
Employees 138,200
CEO Joaquin Duato

Contact Details

Address:
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States
Phone 732 524 0400
Website jnj.com

Stock Details

Ticker Symbol 1JNJ
Exchange Borsa Italiana
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 2834

Key Executives

Name Position
Joaquin Duato Chief Executive Officer
Joseph Wolk Chief Financial Officer
Darren Snellgrove Head of Investor Relations